Importance of diversity in pharma and clinical trials –

Importance of diversity in pharma and clinical trials –

A notable example is the relative lack of Black participants in cardiology trials. Black patients are 30% more likely to die from heart disease than non-Hispanic whites but account for less than 3% of clinical trial participants, truly highlighting the need for improved clinical trial recruitment and revised eligibility criteria.

https://pharmaphorum.com/r-d/importance-diversity-pharma-and-clinical-trials-impetus/

Related Articles

Responses